Invesco S&P MidCap Quality ETF (XMHQ) Holdings

이 페이지는 영어 원문에서 AI로 기계 번역되었습니다. 영어 버전이 기준입니다. 영어 버전 읽기

정보 제공만을 목적으로 합니다. 재정적 조언이 아닙니다.

빠른 답변

Invesco S&P MidCap Quality ETF (XMHQ) has a last stored price of $116.86, as of the Oct 26, 2026 trading session. It has a 0.31% expense ratio and $5.0B in assets under management.

Holdings and weights below are as of Mar 15, 2026. In the stored portfolio snapshot, the largest listed holding is TechnipFMC PLC (FTI) at 4.31%, and the largest sector allocation is Industrials at 25.9%.

Invesco S&P MidCap Quality ETF (XMHQ) ETF — Price, Holdings & Analysis

ETF 개요

XMHQ aims to provide investors with exposure to mid-sized U.S. companies exhibiting strong quality characteristics. The fund tracks the S&P MidCap 400 Quality Index, which selects approximately 80 stocks from the S&P MidCap 400 based on a composite quality score. This score is derived from factors evaluating profitability, earnings quality, and balance sheet strength. The fund invests at least 90% of its assets in securities within the index. Top holdings include TechnipFMC PLC (4.31%), Illumina Inc (3.73%), and United Therapeutics Corp (3.48%). Sector allocation is heavily weighted towards Industrials (25.9%), Healthcare (20.0%), and Financial Services (15.1%). XMHQ is rebalanced semi-annually. This ETF may appeal to investors seeking a quality-focused approach to mid-cap equity exposure, potentially offering a more resilient portfolio compared to broader market indices. Past performance does not guarantee future results.

위험 지표

XMHQ, while diversified across approximately 80 holdings, exhibits some concentration risk with its top 10 holdings accounting for roughly 28.6% of the fund's assets. Sector allocation also presents a risk, with significant exposure to Industrials and Healthcare, making the fund sensitive to sector-specific downturns. The fund's beta of 1.14 indicates that it is more volatile than the broader market. The expense ratio of 0.31% will create a slight drag on performance over time. These factors may be worth researching when evaluating XMHQ's suitability for their portfolio. Past performance does not guarantee future results.

베타: 1.14

운용보수율

0.31%

XMHQ은(는) 무엇을 보유하고 있나요?

보유 종목	비중
TechnipFMC PLC (FTI)	4.31%
Illumina Inc (ILMN)	3.73%
United Therapeutics Corp (UTHR)	3.48%
Royal Gold Inc (RGLD)	3.03%
Carlisle Companies Inc (CSL)	3.02%
Medpace Holdings Inc (MEDP)	2.71%
Carpenter Technology Corp (CRS)	2.50%
Twilio Inc Class A (TWLO)	2.43%
BWX Technologies Inc (BWXT)	2.21%
Nextpower Inc Class A (NXT)	2.21%

보유 종목 및 비중: 2026년 3월 15일 기준. 이 펀드 데이터는 45일 이상 지났습니다. 최신 보유 종목은 발행사에서 확인하세요.

펀드는 어떻게 배분되어 있나요?

섹터	비중
산업재	25.9%
헬스케어	20.0%
금융 서비스	15.1%
기술	11.4%
경기소비재	10.2%
에너지	6.0%
기초 소재	5.4%
필수소비재	3.9%
유틸리티	2.2%

국가	비중
미국	91.3%
영국	4.3%
버뮤다	3.3%
스웨덴	1.1%

배당수익률

0.61%

iShares Morningstar Small-Cap Growth ETF (JKK) — 0.06% expense ratio
ARK Innovation ETF (ARKK) — 0.75% expense ratio
Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio

Invesco Growth Multi-Asset Allocation ETF (PSMG) (Equity) — 0.32% expense ratio
Invesco S&P SmallCap Industrials ETF (PSCI) (Equity) — 0.29% expense ratio
Invesco Top QQQ ETF (QBIG) (Equity) — 0.38% expense ratio
Invesco Russell 2000 Dynamic Multifactor ETF (OMFS) (Equity) — 0.39% expense ratio
Invesco S&P SmallCap 600 Pure Value ETF (RZV) (Equity) — 0.35% expense ratio

질문 및 답변

What is XMHQ and what does it track?

The Invesco S&P MidCap Quality ETF (XMHQ) is an exchange-traded fund that aims to replicate the performance of the S&P MidCap 400 Quality Index.

This index is composed of approximately 80 stocks from the S&P MidCap 400 Index that exhibit the highest quality scores.

What is the expense ratio for XMHQ?

The expense ratio for XMHQ is 0.31%. This means that for every $10,000 invested in the fund, investors will pay $31 in annual fees to cover the fund's operating expenses.

While this is not the lowest expense ratio available in the equity ETF universe, it is competitive within the mid-cap quality ETF category.

What are the top holdings in XMHQ?

As of 2026-03-15, the top holdings in XMHQ include TechnipFMC PLC, comprising 4.31% of the fund's assets. Illumina Inc represents 3.73% of the portfolio, followed by United Therapeutics Corp at 3.48%.

Royal Gold Inc accounts for 3.03% and Carlisle Companies Inc rounds out the top 5 at 3.02%. These holdings reflect the fund's focus on companies with strong quality metrics within the mid-cap space.

Is XMHQ a good long-term investment?

XMHQ's suitability as a long-term investment depends on an individual investor's risk tolerance, investment goals, and time horizon.

The fund's focus on quality mid-cap companies may offer a degree of downside protection during market downturns, but its beta of 1.14 suggests it can be more volatile than the broader market.

How does XMHQ compare to similar ETFs?

XMHQ differentiates itself through its focus on quality factors within the S&P MidCap 400 Index. Other mid-cap ETFs may track different indices, employ different weighting methodologies, or focus on different investment themes such as growth or value.

XMHQ's expense ratio of 0.31% is competitive with other quality-focused mid-cap ETFs. The fund's AUM of $5.00 billion indicates a substantial investor interest.

Does XMHQ pay dividends?

Yes, XMHQ does pay dividends. The current dividend yield for XMHQ is 0.61%. This means that for every $100 invested in the fund, investors can expect to receive $0.61 in dividend payments annually.

It's important to note that dividend yields can fluctuate over time depending on the performance of the underlying holdings and the fund's distribution policy. Investors seeking income may find XMHQ's dividend yield an attractive feature.

면책 조항: 이 콘텐츠는 정보 제공만을 목적으로 하며 투자 조언을 구성하지 않습니다. 항상 자체 조사를 수행하고 재정 고문과 상담하십시오.

데이터는 정보 제공만을 목적으로 제공됩니다.

이 페이지는 기계가 작성했으며, 페이지별 사람 검수는 거치지 않았습니다. 편집 관리는 체계 차원에서 이루어집니다: 규칙과 출처를 점검하며, 개별 페이지는 점검하지 않습니다.